R&D Expenses means Allowable Expenses incurred in connection with research and development of the Product, including, without limitation, manufacture of research and clinical supplies of the Product, determined in accordance with the termns of Section 4.2 of the Collaboration Agreement and with the accounting methodologies set forth in Schedule F to the Collaboration Agreement.
R&D Expenses. Notwithstanding the provisions of Section 2.3 of the Agreement (as amended pursuant to the Third and Fourth Letter Amendments), DuPont and Genencor agree that as of 1st January, 2002 and for the remaining term of the Agreement as extended by this Fifth Letter Amendment, DuPont shall pay Genencor for R&D expenses for work on the R&D Program at the rate of [...***...] per each of the full time Scientific Personnel assigned to the R&D Program. The rate set for Scientific Personnel includes the cost of Support Personnel and overhead. It is anticipated that the level of staffing prior to the effective date of the extension shall be between [...***...] full time Scientific Personnel. Furthermore, it is anticipated that the level of staffing after the effective date of the extension (1 January 2002) shall be [...***...] full time Scientific Personnel, although the actual number shall remain under the direction and adjustment of the Steering Committee.
R&D Expenses shall have the meaning set forth in Section 1.4(a).
Examples of R&D Expenses in a sentence
Included in the R&D Expenses line within the accompanying consolidated statement of income.
The Company shall provide the LLC with product research and development services, engineering support, patent services, as well as manufacture the Products for sale by the LLC, all pursuant to the Budget of Approved R&D Expenses.
The Agreement on Inter-Company Reimbursement of R&D Expenses dated April 1, 2007 between Provider and recipient shall not be assigned by Provider.
In order to receive the necessary funding for the conduct of all Approved R&D Expenses and all other Expenses set forth in the Budget, the Company shall be allowed to draw down upon the Initial Note on the first of each month an advance of $100,000, and within seven days thereafter provide a reconciliation of previous months expenditures and the balance of the account to date.
Except as otherwise provided in this Agreement, [*] and [*] shall [*] ([*]%) [*] the cost and expense of all Authorized R&D Expenses (as defined below) incurred by or on behalf of the Parties in connection with their activities other than the Seattle Genetics Research Activities and the Medarex Research Activities.
More Definitions of R&D Expenses
R&D Expenses shall have the meaning set forth in Section 6.7(b). (108) “Representatives” means, with respect to any Person, any of such Person’s directors, officers, employees, agents, consultants, advisors, accountants, attorneys or other representatives. (109) “Retained Names and Marks” shall have the meaning set forth in Section 6.6. (110) “Reverse Termination Fee” shall have the meaning set forth in Section 8.3(b)(i). (111) “Right of First Negotiation” means the right, but not an obligation, of Buyer to negotiate, before any other Person, a license of the applicable Hydroxy-Compound from Cyclerion. (112) “Second Tranche” means the purchase and sale of the Second Tranche Shares (as defined in the Buyer Parent Purchase Agreement) pursuant to the terms of the Buyer Parent Purchase Agreement. (113) “Securities Act” means the Securities Act of 1933. (114) “Specified Employees” shall have the meaning set forth in Section 6.5(a). (115) “Stockholder Agreements” means the Voting Rights Agreement, Investor Rights Agreement and Right of First Refusal and Co-Sale Agreement of Buyer Parent, in each case in substantially the form set forth on Exhibit C as well as the Cyclerion Stockholder Letter. (116) “Stockholder Approval” shall have the meaning set forth in Section 6.9(a). (117) “Stockholders Meeting” shall have the meaning set forth in Section 6.9(a). (118) “Straddle Period” means any taxable period beginning on or prior to the Closing Date and ending after the Closing Date. (119) “Subsidiary” means with respect to any Person (i) a corporation, fifty percent (50%) or more of the voting or capital stock of which is, as of the time in question, directly or indirectly owned by such Person and (ii) any other Person in which such Person, directly or indirectly, owns fifty percent (50%) or more of the equity or economic interest thereof or has the power to elect or direct the election of fifty percent (50%) or more of the members of the governing body of such Person.
R&D Expenses means the expenses incurred by either Sepracor or Jansxxx xx for their account which are incurred under the R&D Plan (as defined hereafter) and the budget to be agreed between the Parties for such R&D Plan and that are specifically attributable to the development of Rx Products for the United States market. R&D Expenses do not include the Pre-Option Clinical Testing or any other studies not in the R&D Plan agreed between the parties to be conducted prior to exercising the option as defined in Section 2.3(a).
R&D Expenses means, without duplication, for any period of computation thereof, the aggregate of all expenses on a consolidated basis made by the Company and its Consolidated Subsidiaries in respect of research and development. "Regulations D, G, T, U and X" shall mean, respectively, Regulations D, G, T, U and X of the Board of Governors of the Federal Reserve System (or any successor), as the same may be amended or supplemented from time to time.
R&D Expenses means research and development expenses of the Partnership including, without limitation, expenses related to the following:
R&D Expenses means the fully-loaded costs, but excluding general corporate overhead, incurred by a Party or for its account, [***] by either Party during the term of the Agreement [***], and ongoing Product support [***] which are consistent with the Development Plan and budget and are specifically attributable to the Product in the Field. "R&D Expenses" shall include the out-of-pocket payments to Third Parties incurred by a Party in carrying out the functions described in the previous sentence.
R&D Expenses shall include the out-of-pocket payments to Third Parties incurred by a Party in carrying out the functions described in the previous sentence.
R&D Expenses means the Direct Costs incurred by [ * ], in the conduct [ * ] of the Agreement[ * ]. “R&D Expenses” shall include the [ * ] incurred by [ * ] in carrying out the functions described in the previous sentence, including [ * ]. Any financial support received from [ * ] shall be [ * ]. In the event that [ * ].